Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-15

Clinical Trial Update: Deciphering Mechanisms Underlying Cancer Immunogenicity [NA]

View source ↗

Summary

A clinical trial exploring mechanisms underlying cancer immunogenicity, sponsored by Institut Claudius Regaud; the study is currently recruiting across several …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Institut Claudius Regaud | Conditions: Head and Neck Cancer, Ovarian Cancer | NA | Status: RECRUITING